Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for targeted perioperative heart rate control in non-cardiac surgery
ISRCTN12903789Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Dec 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Myocardial injury comparing Ivabradine with Placebo (2 arms). Primary endpoints: Composite of myocardial injury associated with morbidity within 7 days of surgery, High-sensitivity troponin-T criterion and 1 more. Started Dec 2021; status: completed.
02
Drugs
ivabradine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on ISRCTN12903789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12903789.